top of page

Multiple Myeloma is a chronic malignancy characterized by slow progression and recurrences.

Application of omics technologies, and bioinformatics approaches  could identify biological pathways and molecules responsible for the onset, progression and resistance to therapy.

Latest News

Asset 8partner 3.png


An interdisciplinary approach bringing together clinicians and researchers aiming to integrate epidemiological, clinical and experimental datasets in order to create a molecular model of cellular processes associated with the onset of active MM and response to therapy. 


Elucidation of risk factors and health determinants associated with Progression of Monoclonal Gammopathies to Multiple Myeloma

In order to achieve the successful complementation of ELMUMY objectives,

the work-plan is wisely organized and split into the following distinct work packages (WPs):

bottom of page